FI954964A - Användande av vWF-haltiga koncentrat som kombinationsterapi vid terapi med antitrombotika och fibrinolytika - Google Patents
Användande av vWF-haltiga koncentrat som kombinationsterapi vid terapi med antitrombotika och fibrinolytika Download PDFInfo
- Publication number
- FI954964A FI954964A FI954964A FI954964A FI954964A FI 954964 A FI954964 A FI 954964A FI 954964 A FI954964 A FI 954964A FI 954964 A FI954964 A FI 954964A FI 954964 A FI954964 A FI 954964A
- Authority
- FI
- Finland
- Prior art keywords
- therapy
- vwf
- antithrombotic
- fibrinolytic
- containing concentrates
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/36—Blood coagulation or fibrinolysis factors
- A61K38/37—Factors VIII
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4437544A DE4437544A1 (de) | 1994-10-20 | 1994-10-20 | Einsatz von vWF-enthaltenden Konzentraten als Kombinationstherapie bei Therapie mit Antithrombotika und Fibrinolytika |
Publications (2)
Publication Number | Publication Date |
---|---|
FI954964A0 FI954964A0 (sv) | 1995-10-18 |
FI954964A true FI954964A (sv) | 1996-04-21 |
Family
ID=6531287
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI954964A FI954964A (sv) | 1994-10-20 | 1995-10-18 | Användande av vWF-haltiga koncentrat som kombinationsterapi vid terapi med antitrombotika och fibrinolytika |
Country Status (20)
Country | Link |
---|---|
US (1) | US5571784A (sv) |
EP (1) | EP0713881A3 (sv) |
JP (1) | JPH08208504A (sv) |
KR (1) | KR960013383A (sv) |
CN (1) | CN1128168A (sv) |
AU (1) | AU708670B2 (sv) |
CA (1) | CA2160975A1 (sv) |
CZ (1) | CZ287878B6 (sv) |
DE (1) | DE4437544A1 (sv) |
FI (1) | FI954964A (sv) |
HR (1) | HRP950525A2 (sv) |
HU (1) | HU219595B (sv) |
IL (1) | IL115652A (sv) |
NO (1) | NO954175L (sv) |
NZ (1) | NZ280274A (sv) |
PL (1) | PL183182B1 (sv) |
SK (1) | SK129695A3 (sv) |
TW (1) | TW398977B (sv) |
UY (1) | UY24063A1 (sv) |
ZA (1) | ZA958838B (sv) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5772629A (en) * | 1995-10-23 | 1998-06-30 | Localmed, Inc. | Localized intravascular delivery of TFPI for inhibition of restenosis in recanalized blood vessels |
AT405485B (de) * | 1997-05-28 | 1999-08-25 | Immuno Ag | Eine das vwf-propeptid enthaltende pharmazeutische präparation |
AT409335B (de) * | 1998-11-10 | 2002-07-25 | Immuno Ag | Pharmazeutisches präparat enthaltend einen rezeptor-antagonisten zur behandlung von blutgerinnungsstörungen |
US6794412B1 (en) * | 1999-03-11 | 2004-09-21 | Bristol-Myers Squibb Pharma Company | Treatment of thrombosis by combined use of a factor Xa inhibitor and aspirin |
EP1148063A1 (de) * | 2000-04-18 | 2001-10-24 | Octapharma AG | Haemostatisch aktives vWF enthaltendes Präparat und Verfahren zu seiner Herstellung |
JP2003284570A (ja) | 2001-04-25 | 2003-10-07 | Chemo Sero Therapeut Res Inst | フォンビルブラント因子(vWF)切断酵素 |
DE102008032361A1 (de) * | 2008-07-10 | 2010-01-21 | Csl Behring Gmbh | Der Einsatz von Faktor VIII und vWF bzw. vWF-enthaltenden Konzentraten zur Therapie der durch Thrombocyten-Inhibitoren induzierte Koagulopathie |
WO2011101242A1 (en) * | 2010-02-16 | 2011-08-25 | Novo Nordisk A/S | Factor viii molecules with reduced vwf binding |
ES2657291T3 (es) | 2013-04-22 | 2018-03-02 | Csl Ltd. | Un complejo covalente de factor de von Willebrand y factor VIII asociado por un puente disulfuro |
TWI580423B (zh) * | 2013-12-24 | 2017-05-01 | 財團法人工業技術研究院 | 緩解或治療痛風之醫藥組合物及其用途 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5198349A (en) * | 1986-01-03 | 1993-03-30 | Genetics Institute, Inc. | Method for producing factor VIII:C and analogs |
US5200510A (en) * | 1987-06-16 | 1993-04-06 | Zymogenetics, Inc. | Method for purifying factor viii:c, von willebrand factor and complexes thereof |
US4774323A (en) * | 1987-06-29 | 1988-09-27 | Rorer Pharmaceutical Corporation | Purification of von Willebrand Factor solutions using gel permeation chromatography |
FR2619314B1 (fr) * | 1987-08-11 | 1990-06-15 | Transgene Sa | Analogue du facteur viii, procede de preparation et composition pharmaceutique le contenant |
GB8823480D0 (en) * | 1988-10-06 | 1988-11-16 | Ciba Geigy Ag | Antidote |
US5204323B1 (en) | 1988-10-06 | 1995-07-18 | Ciba Geigy Corp | Hirudin antidotal compositions and methods |
FR2673632A1 (fr) * | 1991-03-08 | 1992-09-11 | Lille Transfusion Sanguine | Procede de preparation de concentre de facteur von willebrand humain de tres haute purete, approprie a un usage therapeutique. |
DE4115453A1 (de) * | 1991-05-11 | 1992-11-12 | Knoll Ag | Neue wirkstoffkombination |
US5366869A (en) * | 1991-11-08 | 1994-11-22 | Sheldon Goldstein | Multiple coagulation test device and method |
DE4203965A1 (de) * | 1992-02-11 | 1993-08-12 | Max Planck Gesellschaft | Antidot fuer hirudin und synthetische thrombininhibitoren |
AU677659B2 (en) * | 1993-04-23 | 1997-05-01 | Bio-Technology General Corporation | Method of enhancing thrombolysis |
-
1994
- 1994-10-20 DE DE4437544A patent/DE4437544A1/de not_active Withdrawn
-
1995
- 1995-09-21 EP EP95114846A patent/EP0713881A3/de not_active Withdrawn
- 1995-09-29 TW TW084110150A patent/TW398977B/zh not_active IP Right Cessation
- 1995-10-16 UY UY24063A patent/UY24063A1/es unknown
- 1995-10-18 IL IL11565295A patent/IL115652A/xx not_active IP Right Cessation
- 1995-10-18 US US08/544,867 patent/US5571784A/en not_active Expired - Fee Related
- 1995-10-18 CZ CZ19952719A patent/CZ287878B6/cs not_active IP Right Cessation
- 1995-10-18 SK SK1296-95A patent/SK129695A3/sk unknown
- 1995-10-18 AU AU34304/95A patent/AU708670B2/en not_active Ceased
- 1995-10-18 CN CN95118715A patent/CN1128168A/zh active Pending
- 1995-10-18 KR KR1019950035874A patent/KR960013383A/ko not_active Application Discontinuation
- 1995-10-18 FI FI954964A patent/FI954964A/sv unknown
- 1995-10-18 HR HRP4437544.1A patent/HRP950525A2/hr not_active Application Discontinuation
- 1995-10-18 NZ NZ280274A patent/NZ280274A/en unknown
- 1995-10-19 NO NO954175A patent/NO954175L/no not_active Application Discontinuation
- 1995-10-19 CA CA002160975A patent/CA2160975A1/en not_active Abandoned
- 1995-10-19 PL PL95311031A patent/PL183182B1/pl unknown
- 1995-10-19 JP JP7270785A patent/JPH08208504A/ja active Pending
- 1995-10-19 ZA ZA958838A patent/ZA958838B/xx unknown
- 1995-10-20 HU HU9503031A patent/HU219595B/hu not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP0713881A3 (de) | 1996-08-21 |
HU219595B (hu) | 2001-05-28 |
PL311031A1 (en) | 1996-04-29 |
IL115652A0 (en) | 1996-01-19 |
ZA958838B (en) | 1996-05-13 |
NO954175D0 (no) | 1995-10-19 |
TW398977B (en) | 2000-07-21 |
CZ287878B6 (cs) | 2001-03-14 |
IL115652A (en) | 2000-08-31 |
HU9503031D0 (en) | 1995-12-28 |
CZ271995A3 (en) | 1996-05-15 |
HUT73762A (en) | 1996-09-30 |
EP0713881A2 (de) | 1996-05-29 |
UY24063A1 (es) | 1995-10-24 |
AU708670B2 (en) | 1999-08-12 |
CA2160975A1 (en) | 1996-04-21 |
PL183182B1 (pl) | 2002-06-28 |
KR960013383A (ko) | 1996-05-22 |
CN1128168A (zh) | 1996-08-07 |
SK129695A3 (en) | 1996-10-02 |
HRP950525A2 (en) | 1997-04-30 |
US5571784A (en) | 1996-11-05 |
NO954175L (no) | 1996-04-22 |
FI954964A0 (sv) | 1995-10-18 |
DE4437544A1 (de) | 1996-04-25 |
NZ280274A (en) | 1997-01-29 |
JPH08208504A (ja) | 1996-08-13 |
AU3430495A (en) | 1996-05-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB9701206D0 (en) | Serine derivatives and their use as therapeutic agents | |
NO20000268L (no) | Anvendelse av Lactobacillus for reduksjon av fibrinogen nivå i blod | |
AU3391395A (en) | Morpholine derivatives and their use as therapeutic agents | |
IL113844A (en) | N-(alpha-ETHYLBENZYL)-3-HYDROXY-2-PHENYLQUINOLINE-4-CARBOXAMIDE AND ITS USE IN THE PREPARATION OF MEDICAMENTS | |
ID17156A (id) | Zat-zat anti koagulan yang berguna dalam pengobatan trombosis | |
GB9613003D0 (en) | N-oxides of morpholine derivatives and their use as therapeutic agents | |
EE9800459A (et) | Spiro-piperidiini derivaadid ja nende kasutamine terapeutiliste toimeainetena | |
GB9515775D0 (en) | Piperidine derivatives and their use as therapeutic agents | |
CY2508B1 (en) | Benzopyrans and their use as therapeutic agents | |
PL332136A1 (en) | Benzamidine derivatives and their application an therapeutic agents being antagonists in respect to ltb-4 | |
FI970534A0 (sv) | Förfaranden och kompositioner som är användbara vid profylax och behandling av endotoxinrelaterade tillstånd | |
FI954964A (sv) | Användande av vWF-haltiga koncentrat som kombinationsterapi vid terapi med antitrombotika och fibrinolytika | |
FI960850A (sv) | Användning av kinoxaliner i kombination med proteasinhibitorer som läkemedel vid behandling av AIDS och/eller HIV-infektioner | |
IL128902A0 (en) | N-(2-benzothiazolyl)-1-piperidineethanamine derivatives their preparation and their use in therapy | |
NO970257L (no) | Bestemmelse av tonisk ovarie-östrogen sekresjon i utvidede terapeutiske regimer | |
GB2294637B (en) | Therapeutic compositions and methods of use | |
AU2548795A (en) | Antithrombin agents in treatment of asthma | |
EP0750511A4 (en) | TREATMENT OF INFLAMMATION BY ADMINISTRATION OF SPECIFIC SULFATASE ENZYMES AND / OR A SULFATATION INHIBITOR | |
IL123156A0 (en) | Benzenesulphonamide derivatives their preparation and their application in therapy | |
DE69528261D1 (de) | Benzopyrane und deren verwendung als therapeutische mittel | |
FI972637A0 (sv) | Användning av K-gruppens vitamin vid behandling av hyperparatyreoidism | |
BR9709219A (pt) | Utilização do brometo de pinaverium na prevenção dos fenômenos proliferativos das células do trata hepatodigestivo e das doenças que daí resultam | |
GB9401745D0 (en) | Improvements in and relating to the administration of medicaments or therapeutic substances | |
ZA982355B (en) | Derivatives of n-(arginyl) benzenesulphonamide their preparation and their use in therapy | |
ZA956757B (en) | Morpholine derivatives and their use as therapeutic agents |